Introduction
============

Epidemiologic studies and clinical trials constantly suggest that lipid management could reduce the risk of recurrent cardiovascular events^[@bib1]--[@bib3])^. In light of existing evidence, the United States^[@bib4],\ [@bib5])^ and European^[@bib6]^, ^[@bib7])^ guidelines recommended the lipid goals of 2.6 mmol/L (100 mg/dL) and \< 1.8 mmol/L (70 mg/dL) for high-risk patients, including those with prior history of coronary heart disease (CHD). The 2013 American College of Cardiology/American Heart Association guidelines recommended a low-density lipoprotein cholesterol (LDL-C) treatment target of ≥ 50% reduction^[@bib8])^. However, most clinical trial data were obtained from Caucasian patients^[@bib5],\ [@bib8]--[@bib12])^, and the concept of therapeutic LDL-C targets and proper use of lipid-lowering drugs may not be identical between Western and Asian populations^[@bib13])^. A rapidly growing body of literature from Asian countries is challenging the "lower is better" hypothesis^[@bib14]--[@bib19])^. The main finding^[@bib20])^ from 13473 acute myocardial infarction (MI) patients in a large-scale, prospective, multicenter Korean MI registry found that patients who achieved the target LDL-C level of \< 70 mg/dL did not have lower risks for cardiovascular events regardless of statin therapy than patients who did not achieve the target LDL-C. The large-scale Japanese Coronary Revascularization Demonstrating Outcome Study in Kyoto^[@bib17])^ investigated 14866 patients who underwent coronary revascularization and found that the risk for major adverse cardiovascular events (MACEs) was significantly higher in the ≥ 120 mg/dl group than in patients with lipid goal levels between 80--99 mg/dL; however, the risk for MACEs was not significantly lower in the \< 80 mg/dL group. Another population-based study^[@bib14])^ using data from 31619 ischemic heart disease patients in Israel concluded that patients with LDL-C levels of 70--100 mg/dL had lower risks of MACEs than those with LDL-C levels at 100--130 mg/dL; however, they failed to observe any additional benefit in the patient group achieving LDL-C \< 70 mg/dL. According to our previous research findings^[@bib21],\ [@bib22])^, we failed to identify the clinical benefits associated with the lipid goal of \< 1.8 mmol/L (70 mg/dL) in Chinese patients. There was an intense debate with regard to the Chinese guidelines on whether the recommended LDL-C reduction target for the high-risk atherosclerotic cardiovascular disease group should be set at LDL-C \< 1.8 mmol/L (70 mg/dl) or \< 2.0 mmol/L (80 mg/dl)^[@bib23],\ [@bib24])^.

In real-world clinical practice, many patients fail to achieve their lipid goals, and the contributing factors vary between individuals, such as use of low doses, limited drug effectiveness, and poor drug adherence^[@bib25]--[@bib27])^. A retrospective cohort study in 29 countries across Asia, Western Europe, Eastern Europe, the Middle East, and Africa on 35121 patients taking lipid-lowering drugs found that LDL-C goal attainment was suboptimal worldwide, particularly in patients with high and very high cardiovascular risks^[@bib27])^. Treating patients on the basis of guideline-recommended cholesterol levels or even below would lead to higher economic burden^[@bib28])^. The Return on Expenditure Achieved for LIpid Therapy (REALITY) study in Europe^[@bib29])^ was among the first to study the association between attainment of treatment goals and lipid-lowering therapy. In Swedish patients, they found that those attaining the treatment goal of \< 3.0 mmol/L during the first year had a 28% higher cost of care^[@bib28])^ than nonachievers, but the cost of cardiovascular-related inpatient care in lipid goal achievers was 40% lower than nonachievers after 2--3 years. Compared with the ample pharmacoepidemiologic studies involving Caucasian patients, the economic burden of failure in lipid goal attainments in Asian countries^[@bib30])^ is not well addressed in literature. The REALITY study in Asia^[@bib31],\ [@bib32])^ focused on the evaluation of the lipid goal attainment rate but left the question of economic burden unanswered.

Aim
===

The aim of the current research was to fill the knowledge gap regarding the following: 1) the lipid goal attainments (namely, the lipid goals of \< 2.6 mmol/L, \< 1.8 mmol/L, \< 2.0 mmol/L, and ≥ 50% LDL-C reduction) in Hong Kong; 2) the association of lipid goal attainments and MACEs; 3) the short-(one year) and long-term (five years) costs of failure in achieving the lipid goals, including the total cost of care and cardiovascular-related cost per person (among which the one-year cost was evaluated as the primary outcome, complemented with a sensitivity analysis on the five-year cost).

Methods
=======

In an attempt to provide such data, we performed a noninterventional secondary cohort analysis of post-percutaneous coronary intervention (PCI) acute coronary syndrome (ACS) patients to assess the costs and consequences of lipid goal attainments under real-life conditions in Hong Kong, China. The current study was based on electronic health records (EHRs) from the Hong Kong Hospital Authority Clinical Data Analysis and Reporting System (CDARS) database.

Our study population consisted of all Chinese ACS patients (identified by the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9 CM) diagnosis codes of 411 and 410) aged above 21 years old who received a first documented PCI in the inclusion period between January 1, 2005, and November 30, 2015 from an acute public hospital, the PCI-capable hospital in the New Territories East Cluster of Hong Kong. The study population was continuously enrolled in CDARS for at least one year after their index PCI procedure and had at least one cholesterol measurement within the first-year follow-up. We defined MACEs in the current study as all-cause death, MI, unstable angina (UA), stroke, and revascularization^[@bib33],\ [@bib34])^ from 30 days post-PCI to the one-year endpoint and identified MACEs by death records and ICD-9 CM codes of 410.x (MI); 411.x (UA); 433.01, 433.11, 433.21, 433.31, 433.81, 433.91, 434.01, 434.11, and 434.91 (stroke); 36.01, 36.02, 36.05, 36.06, and 36.09 (PCI); and 36.1 (coronary artery bypass graft). If the patient died within one month after the PCI, he/she was excluded from the analysis regarding the association of MACEs and the latest LDL-C goal before MACE because recurrent events that occurred within the first month might be largely related to the index PCI procedure^[@bib35]--[@bib40])^. The lipid goals under investigation were \< 1.8 mmol/L (70 mg/dL), 2.6 mmol/L (100 mg/dL), \< 2.0 mmol/L (80 mg/dl), and ≥ 50% reduction from baseline. The endpoint lipid goal at the one-year follow-up and the latest lipid goal before the first MACE were studied separately. The latest LDL-C measurement before the MACE was taken from the most recent laboratory results prior to the first MACE day, but it might not be necessarily the endpoint lipid measurement at the one-year follow-up. Considering that the measurement of LDL-C levels at the index ACS event was not a routine clinical practice in Hong Kong, the baseline LDL-C measurements were extracted from the laboratory results nearest to the index PCI procedure (within the period between 180 days prior to the index PCI day and 365 days after the index day). For patients who only had one laboratory result during the index day and after 365 days but had no prior LDL-C measurement between −180 and 0 days, their baseline LDL-C levels could be missing. The patients\' prior disease history, including comorbidities of diabetes and hypertension, and prior cardiovascular disease (CVD) history were obtained from the ICD-9 CM codes in the system in the past six months prior to the index PCI procedure day.

The economic evaluation of interest was the total (direct) cost of care and the cardiovascular-related (inpatient and outpatient) cost from the provider perspective. The total cost of care included the costs for inpatient care, outpatient visits, revascularization procedures, lipid-lowering drugs, and laboratory tests (lipid tests) in the public sectors of Hong Kong. The cardiovascular-related cost in this evaluation was defined as the sum of all the costs of the first-year management of the patient for any cardiovascular-related events (identified by ICD-9 CM code 390. xx-459.xx), including inpatient hospitalization, accident and emergency department admission, and outpatient visits for cardiovascular conditions. The cost for inpatient care was estimated using the length of stay in the hospital from the CDARS and standardized daily cost. The estimation of in-hospital care cost by length of stay and cost per hospital bed day was a common practice by the World Health Organization^[@bib42])^, and the unit cost (cost per hospital bed day) was found in the Hong Kong Government Gazette.

Cost items were also available on all contacts with outpatient hospital services and each attendance at a general clinic would cost HKD 385 (USD 49.4) locally. The unit costs of all direct medical items were based on the 2013 Hong Kong Government Gazette (an official source for medical charges in local public hospitals^[@bib43])^). All costs were estimated in Hong Kong dollars and were converted to US dollars by using the conversion rate USD 1=HKD 7.8 as of March 9, 2018^[@bib44])^, when applicable.

Statistical Methods
-------------------

Descriptive statistics were used to analyze the demographic data, baseline characteristics, and lipid profile parameters (**[Table 1](#T1){ref-type="table"}**). In **[Supplementary Table 1](#T6){ref-type="table"}**, the crude cost items of interest are presented. To identify the influential contributors to the total cost of care, **[Supplementary Table 1](#T6){ref-type="table"}** presents the rundown listing of all the target cost items per person, which include the following: the total cost of care, cardiovascular-related inpatient cost, cardiovascular-related outpatient cost, cardiovascular-related cost (including inpatient and outpatient costs), cost of lipid-lowering therapy (statins and other lipid-lowering drugs), and other management cost (deducting the cardiovascular-related cost from total cost of care). The differences in the abovementioned detailed costs between lipid goal achievers and nonachievers were examined using the treatment effect estimation of multivalued treatment effects^[@bib45],\ [@bib46])^ by adjusting for available potential confounders such as age, sex, diabetes, hypertension, and prior CVD history (**[Tables 2](#T2){ref-type="table"}** and **[3](#T3){ref-type="table"}** for "analyzed sample," **[Supplementary Table 2](#T7){ref-type="table"}** and **[Supplementary Table 3](#T8){ref-type="table"}** for the "full sample," **[Supplementary Table 4](#T9){ref-type="table"}** for cardiovascular-related inpatient cost and cardiovascular-related outpatient cost). Considering that the costs were all positive and were not necessarily following the normality, we used the Poisson option inside the outcome model specification^[@bib47])^. Multivariable Cox regression analyses (**[Table 4](#T4){ref-type="table"}**) were performed to assess the associations of MACEs with the LDL-C goal attainments before MACE after adjusting for age, sex, diabetes, hypertension, and prior CVD history.

###### Descriptive of the subjects

                                                                        *n* (Column %)
  --------------------------------------------------------------------- ----------------
  Total                                                                 4638
  Mean age (SD)                                                         70.23 (10.99)
  Sex: Male                                                             3571 (76.99)
  Previous CVD% (with respective ICD-9 CM code)                         2223 (47.93)
      Hypertensive disease (401--405)                                   451 (9.72)
      Ischemic heart disease (410--414)                                 1278 (27.55)
      Coronary Artery Disease (414)                                     36 (0.78)
      CVA, stroke (434.91)                                              13 (0.28)
      Atrial fibrillation (427.31)                                      46 (0.99)
      Heart failure (428)                                               147 (3.17)
      Carotid artery stenosis/occlusion (433)                           3 (0.06)
      Cerebral atherosclerosis/ischemic cerebrovascular disease (437)   6 (0.13)
      Others                                                            243 (5.24)
  Comorbidity: Hypertension                                             901 (19.43)
  Comorbidity: Diabetes                                                 795 (17.14)
  Baseline cholesterol                                                  4182
      Mean Total (SD)                                                   4.65 (1.18)
      Mean LDL-C (SD)                                                   2.77 (1.05)
      Mean HDL-C (SD)                                                   1.16 (0.32)
      Mean triglycerides (SD)                                           1.6 (0.97)
  Baseline LDL-C category                                               4182
      \< 1.8mmol/L                                                      675 (16.14)
      1.8--2.6mmol/L                                                    1328 (31.76)
      \> 2.6mmol/L                                                      2179 (52.10)
  LDL-C reduction ≥ 50% before MACE                                     633 (15.14)
  LDL-C reduction ≥ 50% at one-year                                     667 (15.95)
  Endpoint LDL-C goal attainments                                       
      1.8 mmol/L                                                        1676 (36.14)
      2.0 mmol/L                                                        2256 (48.64)
      2.6 mmol/L                                                        3687 (79.50)
  Endpoint LDL-C                                                        4638
      \< 1.8 mmol/L                                                     1676 (36.14)
      1.8--2.6 mmol/L                                                   2011 (43.36)
      \> 2.6 mmol/L                                                     951 (20.5)
  Latest LDL-C goal attainments before MACE                             
      1.8 mmol/L                                                        1642 (35.50)
      2.0 mmol/L                                                        2214 (47.87)
      2.6 mmol/L                                                        3644 (78.79)
  Latest LDL-C category before MACE                                     4625
      \< 1.8 mmol/L                                                     1642 (35.50)
      1.8--2.6 mmol/L                                                   2002 (43.29)
      \> 2.6 mmol/L                                                     981 (21.21)
  MACE                                                                  528 (11.38)
      Recurrent PCI between 30 and 365 days                             254 (5.56)
      Recurrent ACS between 30 and 365 days                             176 (3.75)
      Stroke                                                            31 (0.69)
      Death between 30 and 365 days                                     54 (1.08)
      Death within the first 30 days after index PCI                    13 (0.30)

MACE, major adverse cardiovascular events; CVA, cerebrovascular accident; LDL-C, low-density lipoprotein cholesterol; ACS, acute coronary syndrome; PCI, percutaneous coronary intervention; CDARS, clinical data analysis and reporting system; ICD-9 CM, International Classification of Diseases, Ninth Revision, Clinical Modification; CVD, cardiovascular diseases; HDL-C, high-density lipoprotein cholesterol; SD, standard deviation.

###### Crude cost items by lipid goal attainments

  Lipid goal attainments                                      *N*    All management cost   All management cost excluding all the cardio-related cost   Cardiovascular-related inpatient cost   Cardiovascular-related outpatient cost   Cardiovascular-related inpatient and outpatient cost   Lipid-lowering therapy (statins and other lipid-lowering drugs)                                                           
  ----------------------------------------------------------- ------ --------------------- ----------------------------------------------------------- --------------------------------------- ---------------------------------------- ------------------------------------------------------ ----------------------------------------------------------------- ---------- ----------- ---------- ----------- --------- ----------
  **Full sample (*n* = 4638)**                                4638   84021.88              (10772.04)                                                  37598.98                                (4820.38)                                34294.78                                               (4396.77)                                                         12010.26   (1539.78)   45954.70   (5891.63)   764.78    (98.05)
  Endpoint LDL-C achieving the goal of 2.6 mmol/L                                                                                                                                                                                                                                                                                                                                                                        
      Not at goal                                             950    85979.66              (11023.03)                                                  44935.63                                (5760.98)                                29061.01                                               (3725.77)                                                         11835.23   (1517.34)   40731.76   (5222.02)   675.92    (86.66)
      At goal                                                 3688   83516.90              (10707.30)                                                  35706.62                                (4577.77)                                35644.75                                               (4569.84)                                                         12055.40   (1545.56)   47301.87   (6064.34)   787.70    (100.99)
  Endpoint LDL-C achieving the goal of 1.8 mmol/L             4638                                                                                                                                                                                                                                                                                                                                                       
      Not at goal                                             2962   82682.57              (10600.33)                                                  38365.84                                (4918.70)                                32431.62                                               (4157.90)                                                         11701.03   (1500.13)   43767.36   (5611.20)   640.65    (82.14)
      At goal                                                 1676   86388.86              (11075.49)                                                  36243.71                                (4646.63)                                37587.55                                               (4818.92)                                                         12556.75   (1609.84)   49820.39   (6387.23)   984.14    (126.17)
  Endpoint LDL-C achieving the goal of 2.0 mmol/L             4638                                                                                                                                                                                                                                                                                                                                                       
      Not at goal                                             2382   83143.60              (10659.44)                                                  39861.10                                (5110.40)                                31382.20                                               (4023.36)                                                         11679.77   (1497.41)   42828.18   (5490.79)   635.40    (81.46)
      At goal                                                 2256   84949.21              (10890.92)                                                  35210.52                                (4514.17)                                37370.04                                               (4791.03)                                                         12359.20   (1584.51)   49255.83   (6314.85)   901.39    (115.56)
  Endpoint LDL-C achieving the reduction of ≥ 50%             4182                                                                                                                                                                                                                                                                                                                                                       
      Not at goal                                             3549   85297.01              (10935.51)                                                  38541.63                                (4941.24)                                34225.65                                               (4387.90)                                                         12504.82   (1603.18)   46712.21   (5988.74)   638.31    (81.83)
      At goal                                                 633    82223.61              (10541.49)                                                  33773.27                                (4329.91)                                37244.65                                               (4774.95)                                                         11205.70   (1436.63)   48450.35   (6211.58)   1484.50   (190.32)
  Endpoint LDL-C category                                     4638                                                                                                                                                                                                                                                                                                                                                       
      \> 2.6 mmol/L                                           950    85979.66              (11023.03)                                                  44935.63                                (5760.98)                                29061.01                                               (3725.77)                                                         11835.23   (1517.34)   40731.76   (5222.02)   675.92    (86.66)
      1.8--2.6 mmol/L                                         2012   81123.37              (10400.43)                                                  35258.99                                (4520.38)                                34025.58                                               (4362.25)                                                         11637.57   (1492.00)   45202.89   (5795.24)   623.98    (80.00)
      \< 1.8 mmol/L                                           1676   86388.86              (11075.49)                                                  36243.71                                (4646.63)                                37587.55                                               (4818.92)                                                         12556.75   (1609.84)   49820.39   (6387.23)   984.14    (126.17)
                                                                                                                                                                                                                                                                                                                                                                                                                         
  **Analyzed sample (*n* = 4625)**                                                                                                                                                                                                                                                                                                                                                                                       
  Latest LDL-C before MACE achieving the goal of 2.6 mmol/L   4625   83927.13              (10759.89)                                                  37691.60                                (4832.26)                                34133.48                                               (4376.09)                                                         12040.65   (1543.67)   46010.37   (5898.76)   766.83    (98.31)
      Not at goal                                             981    89092.49              (11422.11)                                                  46677.64                                (5984.31)                                30467.26                                               (3906.06)                                                         11909.24   (1526.83)   42298.15   (5422.84)   714.08    (91.55)
      At goal                                                 3644   82536.57              (10581.61)                                                  35272.47                                (4522.11)                                35120.47                                               (4502.62)                                                         12076.03   (1548.21)   47009.73   (6026.89)   781.03    (100.13)
  Latest LDL-C before MACE achieving the goal of 1.8 mmol/L   4625                                                                                                                                                                                                                                                                                                                                                       
      Not at goal                                             2983   83178.75              (10663.94)                                                  38433.26                                (4927.34)                                32886.29                                               (4216.19)                                                         11764.48   (1508.27)   44578.84   (5715.24)   667.50    (85.58)
      At goal                                                 1642   85286.70              (10934.19)                                                  36344.23                                (4659.52)                                36399.25                                               (4666.57)                                                         12542.37   (1608.00)   48611.00   (6232.18)   947.28    (121.45)
  Latest LDL-C before MACE achieving the goal of 2.0 mmol/L   4625                                                                                                                                                                                                                                                                                                                                                       
      Not at goal                                             2411   84468.93              (10829.35)                                                  40280.41                                (5164.16)                                32329.59                                               (4144.82)                                                         11749.64   (1506.36)   43994.11   (5640.27)   658.84    (84.47)
      At goal                                                 2214   83337.12              (10684.25)                                                  34872.44                                (4470.83)                                36097.89                                               (4627.93)                                                         12357.57   (1584.30)   48206.02   (6180.26)   884.43    (113.39)
  Latest LDL-C before MACE achieving the reduction of ≥ 50%   4180                                                                                                                                                                                                                                                                                                                                                       
      Not at goal                                             3547   85314.22              (10937.72)                                                  38563.37                                (4944.02)                                34233.07                                               (4388.86)                                                         12511.87   (1604.09)   46738.55   (5992.12)   652.17    (83.61)
      At goal                                                 633    82223.61              (10541.49)                                                  33773.27                                (4329.91)                                37244.65                                               (4774.95)                                                         11205.70   (1436.63)   48450.35   (6211.58)   1454.30   (186.45)
  Latest LDL-C before MACE category                           4625                                                                                                                                                                                                                                                                                                                                                       
      \> 2.6 mmol/L                                           981    89092.49              (11422.11)                                                  46677.64                                (5984.31)                                30467.26                                               (3906.06)                                                         11909.24   (1526.83)   42298.15   (5422.84)   714.08    (91.55)
      1.8--mmol/L                                             2002   80280.96              (10292.43)                                                  34393.44                                (4409.41)                                34071.63                                               (4368.16)                                                         11693.55   (1499.17)   45696.40   (5858.51)   644.68    (82.65)
      \< 1.8 mmol/L                                           1642   85286.70              (10934.19)                                                  36344.23                                (4659.52)                                36399.25                                               (4666.57)                                                         12542.37   (1608.00)   48611.00   (6232.18)   947.28    (121.45)

MACE indicates major adverse cardiovascular events; LDL-C, low-density lipoprotein cholesterol; HKD, Hong Kong Dollars; USD, United States Dollars.

###### Adjusted cost difference in the total cost of care and cardiovascular-related cost by lipid goal attainments

                                                                     Total cost of care (HKD)   Cardiovascular-related cost (HKD)                                            
  ----------------------------------------------------------- ------ -------------------------- ----------------------------------- ------- --------- ---------------------- -------
  **Analyzed sample**                                                                                                                                                        
  Latest LDL-C before MACE achieving the goal of 2.6 mmol/L   4625                                                                                                           
      Not at goal                                             947    Ref                                                                    Ref                              
      At goal                                                 3678   −4994.14                   (−13597.38, 3609.10)                0.255   4846.70   (1355.73, 8337.66)     0.007
  Latest LDL-C before MACE achieving the goal of 1.8 mmol/L   4625                                                                                                           
      Not at goal                                             2950   Ref                                                                    Ref                              
      At goal                                                 1675   1385.40                    (−5911.87, 8682.68)                 0.710   3414.99   (−487.42, 7317.40)     0.086
  Latest LDL-C before MACE achieving the goal of 2.0 mmol/L   4625                                                                                                           
      Not at goal                                             2374   Ref                                                                    Ref                              
      At goal                                                 2251   −1893.70                   (−8656.95, 4869.55)                 0.583   3565.83   (−25.09, 7156.76)      0.052
  Latest LDL-C before MACE achieving the reduction of ≥ 50%   4180                                                                                                           
      Not at goal                                             3547   Ref                                                                    Ref                              
      At goal                                                 633    7485.89                    (−5483.54, 20455.32)                0.258   5861.97   (−1088.23, 12812.17)   0.098
  Latest LDL-C before MACE category                           4625                                                                                                           
      \> 2.6 mmol/L                                           947    Ref                                                                    Ref                              
      1.8--2.6 mmol/L                                         2003   −6770.82                   (−15760.27, 2218.63)                0.140   3918.44   (−26.17, 7863.05)      0.052
      \< 1.8 mmol/L                                           1675   −2937.15                   (−12802.03, 6927.73)                0.560   6005.66   (1690.23, 10321.08)    0.006
                                                                                                                                                                             
  **Among those baseline LDL-C \> 2.6 mmol/L**                2177                                                                                                           
  Latest LDL-C before MACE achieving the goal of 2.6 mmol/L   2177                                                                                                           
      Not at goal                                             585    Ref                                                                    Ref                              
      At goal                                                 1592   −9274.95                   (−20211.78, 1661.87)                0.096   3009.52   (−1782.19, 7801.23)    0.218
  Latest LDL-C before MACE achieving the goal of 1.8 mmol/L   2177                                                                                                           
      Not at goal                                             1535   Ref                                                                    Ref                              
      At goal                                                 642    −960.01                    (−11895.72, 9975.70)                0.863   3486.48   (−2322.27, 9295.23)    0.239
  Latest LDL-C before MACE achieving the goal of 2.0 mmol/L   2177                                                                                                           
      Not at goal                                             1275   Ref                                                                    Ref                              
      At goal                                                 903    −2112.09                   (−11778.81, 7554.62)                0.668   5159.30   (−309.52, 10628.12)    0.064
  Latest LDL-C before MACE achieving the reduction of ≥ 50%   2177                                                                                                           
      Not at goal                                             1603   Ref                                                                    Ref                              
      At goal                                                 574    7611.84                    (−4473.77, 19697.46)                0.217   6751.11   (−297.54, 13799.76)    0.060
  Latest LDL-C before MACE category                           2177                                                                                                           
      \> 2.6 mmol/L                                           585    Ref                                                                    Ref                              
      1.8--2.6 mmol/L                                         950    −10335.72                  (−21762.04, 1090.59)                0.076   2157.93   (−3304.57, 7620.44)    0.439
      \< 1.8 mmol/L                                           642    −7167.12                   (−20738.06, 6403.83)                0.301   4521.06   (−1791.19, 10833.30)   0.160

MACE, major adverse cardiovascular events; LDL-C, low-density lipoprotein cholesterol; HKD, Hong Kong dollars; Ref, reference.

Adjusted for age, sex, diabetes, hypertension, and prior cardiovascular history

###### Adjusted cost difference in other management cost and the cost of lipid-lowering therapy by lipid goal attainments

                                                                     Other management cost (defined as total cost of care excluding the cardiovascular-related (inpatient and outpatient) cost) (HKD)   Cost of lipid-lowering therapy (statin and other lipid-lowering drugs) (HKD)                                                    
  ----------------------------------------------------------- ------ ---------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------ ---------- ------- --------- --------- --------- ----------
  **Analyzed sample**                                                                                                                                                                                                                                                                                                                   
  Latest LDL-C before MACE achieving the goal of 2.6 mmol/L   4625                                                                                                                                                                                                                                                                      
      Not at goal                                             947    Ref                                                                                                                                                                                                                                  Ref                           
      At goal                                                 3678   −9937.53                                                                                                                           −17166.93                                                                      −2708.14   0.007   66.43     −35.63    168.50    0.202
  Latest LDL-C before MACE achieving the goal of 1.8 mmol/L   4625                                                                                                                                                                                                                                                                      
      Not at goal                                             2950   Ref                                                                                                                                                                                                                                  Ref                           
      At goal                                                 1675   −2252.01                                                                                                                           −7796.22                                                                       3292.19    0.426   272.35    183.19    361.51    \< 0.001
  Latest LDL-C before MACE achieving the goal of 2.0 mmol/L   4625                                                                                                                                                                                                                                                                      
      Not at goal                                             2374   Ref                                                                                                                                                                                                                                  Ref                           
      At goal                                                 2251   −5538.07                                                                                                                           −10675.99                                                                      −400.16    0.035   222.30    139.32    305.29    \< 0.001
  Latest LDL-C before MACE achieving the reduction of ≥ 50%   4180                                                                                                                                                                                                                                                                      
      Not at goal                                             3547   Ref                                                                                                                                                                                                                                  Ref                           
      At goal                                                 633    1578.91                                                                                                                            −8297.82                                                                       11455.64   0.754   667.28    508.35    826.21    \< 0.001
  Latest LDL-C before MACE category                           4625                                                                                                                                                                                                                                                                      
      \> 2.6 mmol/L                                           947    Ref                                                                                                                                                                                                                                  Ref                           
      1.8--2.6 mmol/L                                         2003   −10721.37                                                                                                                          −18081.72                                                                      −3361.01   0.004   −65.52    −173.06   42.03     0.232
  \< 1.8 mmol/L                                               1675   −9176.30                                                                                                                           −17309.22                                                                      −1043.37   0.027   227.61    109.81    345.41    \< 0.001
                                                                                                                                                                                                                                                                                                                                        
  **Among those baseline LDL-C \> 2.6 mmol/L**                                                                                                                                                                                                                                                                                          
  Latest LDL-C before MACE achieving the goal of 2.6 mmol/L   2177                                                                                                                                                                                                                                                                      
      Not at goal                                             585    Ref                                                                                                                                                                                                                                  Ref                           
      At goal                                                 1592   −12256.63                                                                                                                          −21228.51                                                                      −3284.75   0.007   27.61     −123.97   179.20    0.721
  Latest LDL-C before MACE achieving the goal of 1.8 mmol/L   2177                                                                                                                                                                                                                                                                      
      Not at goal                                             1535   Ref                                                                                                                                                                                                                                  Ref                           
      At goal                                                 642    −4403.03                                                                                                                           −12882.10                                                                      4076.04    0.309   325.712   167.917   483.507   \< 0.001
  Latest LDL-C before MACE achieving the goal of 2.0 mmol/L   2177                                                                                                                                                                                                                                                                      
      Not at goal                                             1275   Ref                                                                                                                                                                                                                                  Ref                           
      At goal                                                 903    −7310.54                                                                                                                           −14527.17                                                                      −93.91     0.047   275.38    135.93    414.82    \< 0.001
  Latest LDL-C before MACE achieving the reduction of ≥ 50%   2177                                                                                                                                                                                                                                                                      
      Not at goal                                             1603   Ref                                                                                                                                                                                                                                  Ref                           
      At goal                                                 574    835.75                                                                                                                             −7993.07                                                                       9664.57    0.853   757.21    582.19    932.24    \< 0.001
  Latest LDL-C before MACE category                           2177                                                                                                                                                                                                                                                                      
      \> 2.6 mmol/L                                           585    Ref                                                                                                                                                                                                                                  Ref                           
      1.8--2.6 mmol/L                                         950    −12471.43                                                                                                                          −21536.32                                                                      −3406.54   0.007   −116.61   −276.62   43.41     0.153
      \< 1.8 mmol/L                                           642    −11605.88                                                                                                                          −22613.40                                                                      −598.36    0.039   250.92    60.07     441.77    0.010

MACE, major adverse cardiovascular events; LDL-C, low-density lipoprotein cholesterol; HKD, Hong Kong dollars; Ref, reference; CI, confidence interval.

Adjusted for age, sex, diabetes, hypertension, and prior cardiovascular history

###### Adjusted cost difference in total cost of care and cardiovascular-related cost by lipid goal attainments

                                                                        Total cost of care (HKD)   Cardiovascular-related inpatient and outpatient cost (HKD)                                                     
  -------------------------------------------------------------- ------ -------------------------- ------------------------------------------------------------ ---------- ------- --------- --------- ---------- ----------
  **Full sample**                                                                                                                                                                                                 
  Endpoint LDL-C achieving the goal of 2.6 mmol/L                4638                                                                                                                                             
      Not at goal                                                950    Ref                                                                                                        Ref                            
      At goal                                                    3688   −759.60                    −9253.72                                                     7734.53    0.861   6739.87   3337.06   10142.69   \< 0.001
  Endpoint LDL-C achieving the goal of mmol/L 1.8                4638                                                                                                                                             
      Not at goal                                                2962   Ref                                                                                                        Ref                            
      At goal                                                    1676   2891.58                    −4362.46                                                     10145.62   0.435   5358.43   1418.34   9298.53    0.008
  Endpoint LDL-C achieving the goal of 2.0 mmol/L                4638                                                                                                                                             
      Not at goal                                                2382   Ref                                                                                                        Ref                            
      At goal                                                    2256   1162.69                    −5568.53                                                     7893.90    0.735   5765.66   2188.53   9342.79    0.002
  Endpoint LDL-C achieving the reduction of ≥ 50%                4182                                                                                                                                             
      Not at goal                                                3549   Ref                                                                                                        Ref                            
      At goal                                                    633    10673.08                   −2193.27                                                     23539.42   0.104   7790.72   949.94    14631.51   0.026
  Endpoint LDL-C category                                        4638                                                                                                                                             
      \> 2.6 mmol/L                                              950    Ref                                                                                                        Ref                            
      1.8--2.6 mmol/L                                            2012   −2594.92                   −11501.67                                                    6311.83    0.568   5078.77   1283.27   8874.28    0.009
      \< 1.8 mmol/L                                              1676   1232.23                    −8507.65                                                     10972.12   0.804   8751.29   4436.00   13066.58   \< 0.001
                                                                                                                                                                                                                  
  **Among those with baseline LDL-C \> 2.6 mmol/L (n = 2179)**                                                                                                                                                    
  Endpoint LDL-C achieving the goal of 2.6 mmol/L                2179                                                                                                                                             
      Not at goal                                                549    Ref                                                                                                        Ref                            
      At goal                                                    1630   −916.76                    −11958.09                                                    10124.56   0.871   6964.52   2373.71   11555.33   0.003
  Endpoint LDL-C achieving the goal of mmol/L 1.8                2179                                                                                                                                             
      Not at goal                                                1512   Ref                                                                                                        Ref                            
      At goal                                                           833.85                     −9921.49                                                     11589.19   0.879   5357.43   −323.41   11038.27   0.065
  Endpoint LDL-C achieving the goal of mmol/L 2.0                2179                                                                                                                                             
      Not at goal                                                1250   Ref                                                                                                        Ref                            
      At goal                                                    929    314.59                     −9539.14                                                     10168.31   0.950   6407.34   994.74    11819.93   0.020
  Endpoint LDL-C achieving the reduction of ≥ 50%                2179                                                                                                                                             
      Not at goal                                                1577   Ref                                                                                                        Ref                            
      At goal                                                    602    11674.81                   −296.01                                                      23645.63   0.056   8915.78   2036.57   15794.99   0.011
  Endpoint LDL-C category                                        2179                                                                                                                                             
      \> 2.6 mmol/L                                              549    Ref                                                                                                        Ref                            
      1.8--2.6 mmol/L                                            963    −1296.78                   −12985.19                                                    10391.63   0.828   5735.21   485.86    10984.55   0.032
      \< 1.8 mmol/L                                              660    −229.20                    −13649.60                                                    13191.20   0.973   8709.78   2657.14   14762.41   0.005

MACE indicates major adverse cardiovascular events; LDL-C, low-density lipoprotein cholesterol; HKD, Hong Kong Dollars; Ref, reference; CI, confidence interval.

Adjusted for age, sex, diabetes, hypertension, and prior cardiovascular history

###### Adjusted cost difference in other management cost and cardiovascular-related cost al by lipid goal attainments

                                                           Other management cost (defined as total cost of care excluding the cardiovascular-related (inpatient and outpatient) cost) (HKD)   Cost of lipid-lowering therapy (statins and other lipid-lowering drugs) (HKD)                                                  
  ------------------------------------------------- ------ ---------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------- ---------- ------- -------- --------- -------- ----------
  **Full sample**                                                                                                                                                                                                                                                                                                            
  Endpoint LDL-C achieving the goal of mmol/L 2.6   4638                                                                                                                                                                                                                                                                     
      Not at goal                                   950    Ref                                                                                                                                                                                                                                   Ref                         
      At goal                                       3688   −7649.69                                                                                                                           −14780.03                                                                       −519.35    0.035   111.84   11.39     212.30   0.029
  Endpoint LDL-C achieving the goal of mmol/L 1.8   4638                                                                                                                                                                                                                                                                     
      Not at goal                                   2962   Ref                                                                                                                                                                                                                                   Ref                         
      At goal                                       1676   −2295.23                                                                                                                           −7762.20                                                                        3171.74    0.411   336.07   247.01    425.12   \< 0.001
  Endpoint LDL-C achieving the goal of mmol/L 2.0   4638                                                                                                                                                                                                                                                                     
      Not at goal                                   2382   Ref                                                                                                                                                                                                                                                               
      At goal                                       2256   −4634.13                                                                                                                           −9738.11                                                                        469.84     0.075   265.48   183.11    347.84   \< 0.001
  Endpoint LDL-C achieving the reduction of ≥ 50%   4182                                                                                                                                                                                                                                                                     
      Not at goal                                   3549   Ref                                                                                                                                                                                                                                   Ref                         
      At goal                                       633    2870.41                                                                                                                            −6875.75                                                                        12616.56   0.564   721.86   565.70    878.02   \< 0.001
  Endpoint LDL-C category                           4638                                                                                                                                                                                                                                                                     
      \> 2.6 mmol/L                                 950    Ref                                                                                                                                                                                                                                   Ref                         
      1.8--2.6 mmol/L                               2012   −7974.68                                                                                                                           −15298.58                                                                       −650.78    0.033   −50.31   −155.59   54.96    0.349
      \< 1.8 mmol/L                                 1676   −7555.90                                                                                                                           −15534.01                                                                       422.20     0.063   300.77   184.00    417.54   \< 0.001
                                                                                                                                                                                                                                                                                                                             
  **Among those baseline LDL-C \> 2.6 mmol/L**                                                                                                                                                                                                                                                                               
  Endpoint LDL-C achieving the goal of mmol/L 2.6   2179                                                                                                                                                                                                                                                                     
      Not at goal                                   549    Ref                                                                                                                                                                                                                                   Ref                         
      At goal                                       1630   −7662.03                                                                                                                           −16812.44                                                                       1488.38    0.101   93.92    −56.79    244.63   0.222
  Endpoint LDL-C achieving the goal of mmol/L 1.8   2179                                                                                                                                                                                                                                                                     
      Not at goal                                   1512   Ref                                                                                                                                                                                                                                   Ref                         
      At goal                                              −4392.23                                                                                                                           −12755.67                                                                       3971.20    0.303   402.64   246.53    558.76   \< 0.001
  Endpoint LDL-C achieving the goal of mmol/L 2.0   2179                                                                                                                                                                                                                                                                     
      Not at goal                                   1250   Ref                                                                                                                                                                                                                                   Ref                         
      At goal                                       929    −6035.74                                                                                                                           −13535.69                                                                       1464.20    0.115   329.98   191.73    468.22   \< 0.001
  Endpoint LDL-C achieving the reduction of ≥ 50%   2179                                                                                                                                                                                                                                                                     
      Not at goal                                   1577   Ref                                                                                                                                                                                                                                   Ref                         
      At goal                                       602    2805.23                                                                                                                            −5949.90                                                                        11560.35   0.530   813.85   642.16    985.54   \< 0.001
  Endpoint LDL-C category                           2179                                                                                                                                                                                                                                                                     
      \> 2.6 mmol/L                                 549    Ref                                                                                                                                                                                                                                   Ref                         
      1.8--2.6 mmol/L                               963    −6818.40                                                                                                                           −16262.66                                                                       2625.86    0.157   −83.74   −241.19   73.71    0.297
      \< 1.8 mmol/L                                 660    −8657.79                                                                                                                           −19624.15                                                                       2308.57    0.122   347.44   157.97    536.90   \< 0.001

MACE indicates major adverse cardiovascular events; LDL-C, low-density lipoprotein cholesterol; HKD, Hong Kong Dollars; Ref, reference; CI, confidence interval.

Adjusted for age, sex, diabetes, hypertension, and prior cardiovascular history

###### Adjusted cost difference in cardiovascular-related inpatient and outpatient costs al by lipid goal attainments

                                                                     Cardiovascular-related inpatient cost (HKD)   Cardiovascular-related outpatient cost (HKD)                                                         
  ----------------------------------------------------------- ------ --------------------------------------------- ---------------------------------------------- ---------- ---------- ---------- ---------- --------- -------
  **Full sample**                                                                                                                                                                                                       
  Endpoint LDL-C achieving the goal of mmol/L 2.6             4638                                                                                                                                                      
      Not at goal                                             950    Ref                                                                                                                Ref                             
      At goal                                                 3688   6563.44                                       3567.08                                        9559.81    \< 0.001   404.88     −764.31    1574.07   0.497
  Endpoint LDL-C achieving the goal of mmol/L 1.8             4638                                                                                                                                                      
      Not at goal                                             2962   Ref                                                                                                                Ref                             
      At goal                                                 1676   4583.37                                       921.54                                         8245.20    0.01       784.66     −106.42    1675.74   0.084
  Endpoint LDL-C achieving the goal of mmol/L 2.0             4638                                                                                                                                                      
      Not at goal                                             2382   Ref                                                                                                                Ref                             
      At goal                                                 2256   5343.24                                       2032.67                                        8653.81    0.002      674.53     −174.16    1523.21   0.119
  Endpoint LDL-C achieving the reduction of 50%               4182                                                                                                                                                      
      Not at goal                                             3549   Ref                                                                                                                Ref                             
      At goal                                                 633    7821.31                                       1379.81                                        14262.81   0.02       −48.28     −1176.01   1079.44   0.933
  Endpoint LDL-C category                                     4638                                                                                                                                                      
      \> 2.6 mmol/L                                           950    Ref                                                                                                                Ref                             
      1.8--2.6 mmol/L                                         2012   −2815.61                                      −6868.01                                       1236.78    0.173      −780.33    −1694.82   134.16    0.094
      \< 1.8 mmol/L                                           1676   −8168.68                                      −12054.67                                      −4282.69   0.00       −797.55    −2091.59   496.49    0.227
                                                                                                                                                                                                                        
  **Analyzed sample**                                                                                                                                                                                                   
  Latest LDL-C before MACE achieving the goal of 2.6 mmol/L   4625                                                                                                                                                      
      Not at goal                                             947    Ref                                                                                                                Ref                             
      At goal                                                 3678   4640.73                                       1550.45                                        7731.00    0.003      310.31     −854.52    1475.14   0.602
  Latest LDL-C before MACE achieving the goal of 1.8 mmol/L   4625                                                                                                                                                      
      Not at goal                                             2950   Ref                                                                                                                Ref                             
      At goal                                                 1675   3026.64                                       −574.43                                        6627.71    0.10       698.51     −205.20    1602.23   0.130
  Latest LDL-C before MACE achieving the goal of 2.0 mmol/L   4625                                                                                                                                                      
      Not at goal                                             2374   Ref                                                                                                                Ref                             
      At goal                                                 2251   3177.62                                       −121.41                                        6476.64    0.059      569.77     −286.25    1425.79   0.192
  Latest LDL-C before MACE achieving the reduction of 50%     4180                                                                                                                                                      
      Not at goal                                             3547   Ref                                                                                                                Ref                             
      At goal                                                 633    6407.96                                       −189.79                                        13005.72   0.06       −556.08    −1639.01   526.85    0.314
  Latest LDL-C before MACE category                           4625                                                                                                                                                      
      \> 2.6 mmol/L                                           947    Ref                                                                                                                Ref                             
      1.8--2.6 mmol/L                                         2003   3939.56                                       402.93                                         7476.19    0.029      −34.05     −1246.45   1178.34   0.956
      \< 1.8 mmol/L                                           1675   5625.88                                       1740.87                                        9510.88    \< 0.001   679.57     −617.86    1977.01   0.305
  **Among those baseline LDL-C \> 2.6 mmol/L**                                                                                                                                                                          
  Endpoint LDL-C achieving the goal of 2.6 mmol/L             2179                                                                                                                                                      
      Not at goal                                             549    Ref                                                                                                                Ref                             
      At goal                                                 1630   7425.07                                       3397.85                                        11452.29   \< 0.001   −522.06    −2070.39   1026.28   0.509
  Endpoint LDL-C achieving the goal of 1.8 mmol/L             2179                                                                                                                                                      
      Not at goal                                             1512   Ref                                                                                                                Ref                             
      At goal                                                        5010.12                                       −258.74                                        10278.98   0.062      317.90     −860.70    1496.49   0.597
  Endpoint LDL-C achieving the goal of 2.0 mmol/L             2179                                                                                                                                                      
      Not at goal                                             1250   Ref                                                                                                                Ref                             
      At goal                                                 929    6119.90                                       1068.21                                        11171.58   0.02       251.80     −853.84    1357.44   0.655
  Endpoint LDL-C achieving the reduction of 50%               2179                                                                                                                                                      
      Not at goal                                             1577   Ref                                                                                                                Ref                             
      At goal                                                 602    8597.60                                       2094.39                                        15100.81   0.01       288.93     −923.39    1501.25   0.640
  Endpoint LDL-C category                                     2179                                                                                                                                                      
      \> 2.6 mmol/L                                           549    Ref                                                                                                                Ref                             
      1.8--2.6 mmol/L                                         963    −2348.39                                      −8314.18                                       3617.40    0.44       −616.14    −1796.81   564.54    0.306
      \< 1.8 mmol/L                                           660    −8779.03                                      −14217.25                                      −3340.82   0.002      131.12     −1569.10   1831.34   0.880
  Latest LDL-C before MACE achieving the goal of 2.6 mmol/L   2177                                                                                                                                                      
      Not at goal                                             585    Ref                                                                                                     Ref                                        
      At goal                                                 1592   3885.39                                       −384.12                                        8154.91    0.074      −878.64    −2371.55   614.28    0.249
  Latest LDL-C before MACE achieving the goal of 1.8 mmol/L   2177                                                                                                                                                      
      Not at goal                                             1535   Ref                                                                                                     Ref                                        
      At goal                                                 642    3319.74                                       −2132.71                                       8772.18    0.23       161.66     −1008.74   1332.06   0.787
  Latest LDL-C before MACE achieving the goal of 2.0 mmol/L   2177                                                                                                                                                      
      Not at goal                                             1275   Ref                                                                                                     Ref                                        
      At goal                                                 903    4957.06                                       −163.92                                        10078.04   0.058      193.57     −915.19    1302.34   0.732
  Latest LDL-C before MACE achieving the reduction of 50%     2177                                                                                                                                                      
      Not at goal                                             1603   Ref                                                                                                     Ref                                        
      At goal                                                 574    6942.93                                       231.22                                         13654.65   0.04       −202.58    −1382.28   977.12    0.736
  Latest LDL-C before MACE category                           2177                                                                                                                                                      
      \> 2.6 mmol/L                                           585    Ref                                                                                                     Ref                                        
      1.8--2.6 mmol/L                                         950    3250.41                                       −1686.73                                       8187.55    0.197      −1086.36   −2671.65   498.94    0.179
      \< 1.8 mmol/L                                           642    5005.76                                       −774.48                                        10786.01   0.09       −485.87    −2131.76   1160.02   0.563

MACE indicates major adverse cardiovascular events; LDL-C, low-density lipoprotein cholesterol; HKD, Hong Kong Dollars; Ref, reference; CI, confidence interval.

Adjusted for age, sex, diabetes, hypertension, and prior cardiovascular history

###### Association of MACEs and lipid goal attainments

                                                                   *n*    Adjusted Hazard Ratio[\*](#tf3){ref-type="table-fn"}   (95% Confidence Interval)   *p*-value
  ---------------------------------------------------------------- ------ ------------------------------------------------------ --------------------------- -----------
  **Analyzed sample**                                                                                                                                        
  Latest LDL-C before MACE achieving the goal of 2.6 mmol/L        4625                                                                                      
      Not at goal                                                  981    1                                                                                  
      At goal                                                      3644   0.76                                                   (0.62, 0.93)                0.007
  Latest LDL-C before MACE achieving the goal of 1.8 mmol/L        4625                                                                                      
      Not at goal                                                  2983   1                                                                                  
      At goal                                                      1642   0.97                                                   (0.81, 1.17)                0.779
  Latest LDL-C before MACE achieving the goal of 2.0 mmol/L        4625                                                                                      
      Not at goal                                                  2411   1                                                                                  
      At goal                                                      2214   0.93                                                   (0.78, 1.10)                0.385
  Latest LDL-C before MACE achieving the goal of ≥ 50% reduction   4180                                                                                      
      Not at goal                                                  3547   1                                                                                  
      At goal                                                      633    0.77                                                   (0.58, 1.03)                0.074
  Latest LDL-C category before MACE                                4625                                                                                      
      \< 1.8 mmol/L                                                1642   1                                                                                  
      1.8--2.6 mmol/L                                              2003   0.92                                                   (0.75, 1.12)                0.396
      \> 2.6 mmol/L                                                981    1.25                                                   (1.00, 1.57)                0.051
                                                                                                                                                             
  **Among those with baseline LDL-C \> 2.6 mmol/L**                                                                                                          
  Latest LDL-C before MACE achieving the goal of 2.6 mmol/L        2177                                                                                      
      Not at goal                                                  585    1                                                                                  
      At goal                                                      1592   0.56                                                   (0.42, 0.74)                \< 0.001
  Latest LDL-C before MACE achieving the goal of 1.8 mmol/L        2177                                                                                      
      Not at goal                                                  1535   1                                                                                  
      At goal                                                      642    0.78                                                   (0.57, 1.06)                0.108
  Latest LDL-C before MACE achieving the goal of 2.0 mmol/L        2177                                                                                      
      Not at goal                                                  1275   1                                                                                  
      At goal                                                      903    0.83                                                   (0.63, 1.10)                0.186
  Latest LDL-C before MACE achieving the goal of ≥ 50% reduction   2177                                                                                      
      Not at goal                                                  1603   1                                                                                  
      At goal                                                      574    0.72                                                   (0.52, 1.00)                0.051
  Latest LDL-C category before MACE                                2177                                                                                      
      \< 1.8 mmol/L                                                642    1                                                                                  
      1.8--2.6 mmol/L                                              950    1.00                                                   (0.71, 1.41)                0.983
      \> 2.6 mmol/L                                                585    1.79                                                   (1.26, 2.55)                0.001

MACE, major adverse cardiovascular events; LDL-C, low-density lipoprotein cholesterol.

Adjusted for age, sex, diabetes, hypertension, and prior cardiovascular history

Sensitivity Analysis
--------------------

Two sensitivity analyses were conducted to test the robustness of our results. As noticed in the early literature^[@bib28])^, patients that reached the lipid goals showed a trend of cost reductions over time. To explore if the costs significantly decreased after one year after the index day, we also examined the average five-year total cost of care among the patients who underwent the index PCI between January 1, 2005, and November 30, 2010, and completed the five-year follow-up. The adjusted differences in the total cost of care and cardiovascular-related cost for this patient group could be found in **[Table 5](#T5){ref-type="table"}** and **[Supplementary Table 5](#T10){ref-type="table"}**. In absolute terms, the baseline LDL-C levels seemed to largely influence the economic and clinical outcomes in terms of their initial effect on physicians\' judgments. Therefore, a sensitivity analysis was conducted among patients with baseline LDL-C beyond 2.6 mmol/L to test the robustness of our results (**[Tables 2](#T2){ref-type="table"}**, **[3](#T3){ref-type="table"}**, and **[4](#T4){ref-type="table"}**).

###### Adjusted cost difference of the total cost of care and cardiovascular-related cost by lipid goal attainments among 2686 patients with complete five-year follow-up

                                                           Total cost of care (HKD)   Cardiovascular-related cost (HKD)                                           
  ------------------------------------------------- ------ -------------------------- ----------------------------------- ------ ---------- --------------------- ----------
  Endpoint LDL-C achieving the goal of 2.6 mmol/L   2686                                                                                                          
      1st year: At goal vs Not at goal              2686   6548.52                    (−3441.94, 16538.97)                0.20   10495.13   (5846.36, 15143.89)   \< 0.001
      2nd year: At goal vs Not at goal              2686   1433.02                    (−6835.65, 9701.69)                 0.73   −1637.26   (−5892.56, 2618.05)   0.45
      3rd year: At goal vs Not at goal              2686   1404.19                    (−6251.35, 9059.74)                 0.72   −7.59      (−3437.71, 3422.53)   1.00
      4th year: At goal vs Not at goal              2686   −4251.30                   (−11714.31, 3211.71)                0.26   −1776.81   (−5662.26, 2108.64)   0.37
      5th year: At goal vs Not at goal              2686   −748.84                    (−7558.02, 6060.34)                 0.83   −1529.18   (−5146.36, 2088.00)   0.41
  Endpoint LDL-C achieving the goal of 1.8 mmol/L   2686                                                                                                          
      1st year: At goal vs Not at goal              2686   12764.70                   (1199.33, 24330.08)                 0.03   8367.48    (1343.69, 15391.27)   0.02
      2nd year: At goal vs Not at goal              2686   10694.72                   (1936.13, 19453.32)                 0.02   739.51     (−2118.36, 3597.39)   0.61
      3rd year: At goal vs Not at goal              2686   4185.83                    (−3570.15, 11941.81)                0.29   2323.03    (−1117.32, 5763.37)   0.19
      4th year: At goal vs Not at goal              2686   −2747.02                   (−9003.42, 3509.38)                 0.39   −1263.53   (−4107.77, 1580.71)   0.38
      5th year: At goal vs Not at goal              2686   367.42                     (−6025.01, 6759.85)                 0.91   21.21      (−2939.33, 2981.74)   0.99
  Endpoint LDL-C achieving the goal of 2.0 mmol/L   2686                                                                                                          
      1st year: At goal vs Not at goal              2686   8031.90                    (−2052.35, 18116.14)                0.12   7683.58    (1678.83, 13688.32)   0.01
      2nd year: At goal vs Not at goal              2686   6080.24                    (−1372.17, 13532.65)                0.11   −167.99    (−2973.12, 2637.14)   0.91
      3rd year: At goal vs Not at goal              2686   1853.03                    (−5091.22, 8797.29)                 0.60   1056.23    (−1890.38, 4002.83)   0.48
      4th year: At goal vs Not at goal              2686   −6025.85                   (−11884.44, −167.25)                0.04   −2474.41   (−5301.74, 352.93)    0.09
      5th year: At goal vs Not at goal              2686   −405.39                    (−6530.61, 5719.83)                 0.90   −1076.21   (−3926.35, 1773.94)   0.46
  Endpoint LDL-C achieving the reduction of 50%     2412                                                                                                          
      1st year: At goal vs Not at goal              2412   16472.69                   (−2613.22, 35558.59)                0.09   10607.64   (297.47, 20917.80)    0.04
      2nd year: At goal vs Not at goal              2412   −3062.50                   (−11721.47, 5596.48)                0.49   −1222.43   (−4448.06, 2003.20)   0.46
      3rd year: At goal vs Not at goal              2412   −1969.65                   (−13188.12, 9248.82)                0.73   −182.27    (−5121.42, 4756.89)   0.94
      4th year: At goal vs Not at goal              2412   −4115.05                   (−13228.67, 4998.58)                0.38   −2179.64   (−5794.71, 1435.42)   0.24
      5th year: At goal vs Not at goal              2412   2065.28                    (−10846.31, 14976.88)               0.75   −1675.69   (−5453.84, 2102.45)   0.38

MACE, major adverse cardiovascular events; LDL-C, low-density lipoprotein cholesterol; HKD, Hong Kong dollars; Ref, reference.

Adjusted for age, sex, diabetes, hypertension, and prior cardiovascular history

###### Adjusted cost difference by lipid goal attainments among 2686 patients with complete five-year follow-up

                            Total cost of care (HKD)   Cardiovascular-related cost (HKD)                                                      
  ------------------------- -------------------------- ----------------------------------- ---------- ------ ---------- ---------- ---------- ----------
  Endpoint LDL-C category                                                                                                                     
      1st year:                                                                                                                               
          \> 2.6 mmol/L     Ref                                                                              Ref                              
          1.8--2.6 mmol/L   1510.38                    −9054.15                            12074.92   0.78   8280.74    3097.21    13464.26   \< 0.001
          \< 1.8 mmol/L     13910.13                   710.44                              27109.82   0.04   13887.91   6831.99    20943.83   \< 0.001
      2nd year:                                                                                                                               
          \> 2.6 mmol/L     Ref                                                                              Ref                              
          1.8--2.6 mmol/L   −3520.93                   −11949.96                           4908.09    0.41   −2387.03   −6707.04   1932.98    0.28
          \< 1.8 mmol/L     8408.82                    −2255.99                            19073.64   0.12   −753.36    −5383.72   3876.99    0.75
      3rd year:                                                                                                                               
          \> 2.6 mmol/L     Ref                                                                              Ref                              
          1.8--2.6 mmol/L   −211.90                    −8450.38                            8026.58    0.96   −1234.08   −4663.44   2195.28    0.48
          \< 1.8 mmol/L     4022.09                    −5283.34                            13327.51   0.40   1649.37    −2653.99   5952.72    0.45
      4th year:                                                                                                                               
          \> 2.6 mmol/L     Ref                                                                              Ref                              
          1.8--2.6 mmol/L   −3680.62                   −11771.91                           4410.68    0.37   −1411.23   −5648.60   2826.13    0.51
          \< 1.8 mmol/L     −5277.79                   −13619.73                           3064.16    0.21   −2267.74   −6382.58   1847.10    0.28
      5th year:                                                                                                                               
          \> 2.6 mmol/L     Ref                                                                              Ref                              
          1.8--2.6 mmol/L   −1029.39                   −8780.01                            6721.23    0.79   −1541.59   −5687.27   2604.09    0.47
          \< 1.8 mmol/L     −342.22                    −8003.73                            7319.29    0.93   −1061.03   −4991.50   2869.43    0.60

MACE indicates major adverse cardiovascular events; LDL-C, low-density lipoprotein cholesterol; HKD, Hong Kong Dollars; Ref, reference; CI, confidence interval.

Adjusted for age, sex, diabetes, hypertension, and prior cardiovascular history

All analyses were performed using Stata 14 (Stata Corporation Lp, College Station, TX). All the patients\' information was de-identified in the database. The study was approved by the Joint Clinical Research Ethics Committee of The Chinese University of Hong Kong and New Territories East Cluster of Hong Kong, and the protocol was compliant with the Declaration of Helsinki.

Results
=======

Our analysis involves 4638 patients (mean age ± standard deviation (SD): 70.23 ± 10.99 years) who have at least one LDL-C measurement via one-year follow-up (**[Table 1](#T1){ref-type="table"}**); these patients are referred to as the "full sample" in **[Supplementary Tables 1](#T6){ref-type="table"}**, **[2](#T7){ref-type="table"}**, **[3](#T8){ref-type="table"}**, and **[4](#T9){ref-type="table"}**. There were 76.99% males, 19.43% of which were hypertensive, 17.14% were diabetic patients, and 47.93% had previous CVD. At the one-year endpoint, approximately 80% and 50% of patient reached the LDL-C goals of 2.6 and 2.0 mmol/L, respectively, and 36.14% were well controlled under 1.8 mmol/L. Among the 4182 patients who had available baseline LDL-C levels, 52.10% had their initial LDL-C levels above 2.6 mmol/L, and only 15.95% achieved ≥ 50% reduction. Among all patients, 515 (11.10%) had at least one incidence of MACE between 30 and 365 days after the index procedure. Thirteen patients died within the first month, and these patients were excluded when we analyzed the latest lipid goal attainment before MACE. After the exclusion, 4625 patients comprised the "analyzed sample" (**[Tables 2](#T2){ref-type="table"}**, **[3](#T3){ref-type="table"}**, and **[4](#T4){ref-type="table"}**).

**[Supplementary Table 1](#T6){ref-type="table"}** reports the crude costs by lipid goal attainments at the one-year endpoint and before their first MACE between the 30th and 365th day, respectively. From the observed crude numbers of **[Supplementary Table 1](#T6){ref-type="table"}**, the lipid goal achievers of \< 1.8 mmol/L carry the highest total cost of care compared with the nonachievers, and the lipid category of 1.8--2.6 mmol/L seems to be more desirable in terms of costs. The adjusted cost differences in the total cost of care and cardiovascular-related cost are presented in **[Tables 2](#T2){ref-type="table"}** and **[3](#T3){ref-type="table"}** (**[Supplementary Tables 2](#T7){ref-type="table"}** and **[3](#T8){ref-type="table"}** for the results of the "full sample") and were controlled for baseline characteristics. After this adjustment, none of the lipid goal attainments of \< 2.6 mmol/L, \< 2.0 mmol/L, \< 1.8 mmol/L, or ≥ 50% reduction was associated with any reduction in the total cost of care during the one-year follow-up. After excluding the cardiovascular-related management costs (in **[Table 3](#T3){ref-type="table"}**), the lipid goal attainment of 2.6 mmol/L either at the one-year endpoint or before MACE seems to be a cost-saving strategy, particularly the category of 1.8--2.6 mmol/L. This finding could imply that among all the detailed cost items, the cardiovascular-related management cost, particularly the cardiovascular-related inpatient cost (shown in **[Supplementary Table 4](#T9){ref-type="table"}**), is the most affected by the lipid goal attainments. Assuming that patients who could attain the lipid goals remarkably differed in baseline characteristics from those who could not, we adjusted for all the available covariates and performed a sensitivity analysis among high-risk patients with LDL-C \> 2.6 mmol/L at baseline. We constantly find that lowering patients\' LDL-C levels to a more stringent goal leads to an increase in cardiovascular-related cost (**[Table 2](#T2){ref-type="table"}**). Upon realizing that the endpoint lipid goal attainment (at the one-year endpoint) was not necessarily the latest lipid goal before the MACE, we evaluated the cost difference by using the latest lipid goal attainments before MACE (**[Table 2](#T2){ref-type="table"}**) and the cost difference by lipid goal attainment at the one-year endpoint (**[Supplementary Table 2](#T7){ref-type="table"}**). It was still noted that the patients attaining more stringent lipid goals had higher costs in cardiovascular-related management. After excluding the cardiovascular-related (inpatient and outpatient) costs, both LDL-C goal attainment groups of \< 2.6 and \< 2.0 mmol/L could substantially increase the cost savings (**[Table 3](#T3){ref-type="table"}**). We expected that those having LDL-C levels below each lipid goal would be on more intensive lipid treatments than those above the goal, and this situation would contribute to the increased cost of reaching a lower level of LDL-C. However, from this current observation, the cardiovascular-related inpatient cost (**[Supplementary Table 4](#T9){ref-type="table"}**) is a more influential contributor to the total cost of care than the intensive lipid treatment cost (**[Table 3](#T3){ref-type="table"}**). In **[Table 5](#T5){ref-type="table"}**, among 2686 patients with a complete 5-year follow-up, no significant differences in any cost items between lipid goal achievers and nonachievers were observed starting from the second year.

**[Table 4](#T4){ref-type="table"}** shows the results from the multivariate Cox regression analysis of the first occurrence of MACE. Separate regressions were performed for lipid goal attainments before MACEs in the analyzed sample and in the patient group with baseline LDL-C above 2.6 mmol/L. The LDL-C goal of \< 2.6 mmol/L was associated with a reduction in MACE but not the goals of 1.8 mmol/L, 2.0 mmol/L, and ≥ 50% reduction. Lowering the LDL-C level attainment from 2.6 mmol/L to 1.8 mmol/L did not improve the clinical outcomes.

Discussion
==========

To our knowledge, this study was the first to investigate the economic burden of failure in achieving the lipid goals in an Asian/Chinese population. Our findings suggested that any LDL-C goal attainments of \< 2.6 mmol/L, \< 2.0 mmol/L, \< 1.8 mmol/L, and ≥ 50% reduction did not necessarily bring any reduction in the total cost of care during a one-year follow-up; this finding was in line with the prior cost analysis in Sweden^[@bib28])^. This was possible because the higher cardiovascular-related cost targeting for more stringent lipid goals offset the savings in other management cost and boosted the total cost of care. In the current analysis, the latest lipid goal attainments before MACEs might not be the same as the lipid goal at the one-year endpoint because lipids changed acutely after MACE^[@bib48],\ [@bib49])^. Therefore, we also tested the cost difference by the latest lipid goal attainments before MACE. The results seemed to be robust to what was found before. Owing to the limitations of the observational study, we could not clarify the causes of the additional cardiovascular-related cost in the "treat-to-target" approaches for the LDL-C goals of \< 2.0 mmol/L, \< 1.8 mmol/L, and ≥ 50% reduction compared with the less intensive LDL-C goal of \< 2.6 mmol/L. One possible reason could be that physicians aggressively treated patients who were at higher risk at baseline to reach a more stringent lipid goal, thus causing additional economic burden. Bearing this potential explanation in mind, we looked at the cost differences in high-risk patients with baseline LDL-C beyond 2.6 mmol/L and still found that lipid categories of 1.8 mmol/L, 2.0 mmol/L, 2.6 mmol/L, and ≥ 50% reduction denoted higher cardiovascular-related costs. The other possible explanation could be that the cost of higher intensive lipid treatment may have been substantially greater because of the use of branded atorvastatin and rosuvastatin rather than generic simvastatin. However, as shown in **[Table 3](#T3){ref-type="table"}**, the cost of lipid-lowering drugs alone was perceived to have little effect on the total cost of care. Normally the future costs were less than the immediate costs, although the future clinical benefits of a longer follow-up were generally less significant than the immediate benefits^[@bib50])^. As a consequence, we took a closer look at the time series changes among patients with five-year follow-up because one Swedish study found that the cardiovascular-related costs for goal-attaining patients decreased significantly 2--3 years after the treatment started^[@bib28])^. However, our results did not show the same "cost reduction" trend in lipid goal achievers. Starting from the second year, there were no significant cost differences between the lipid goal achievers and nonachievof ers.

Taken together, if attainment of a more stringent lipid goal accompanied a higher cardiovascular-related cost, it would be important to determine if the attainment of the lower lipid goal could also lead to improved clinical outcomes. Therefore, we examined if the lipid goal attainments of 1.8 mmol/L, 2.0 mmol/L, 2.6 mmol/L, and ≥ 50% reduction could lead to significant reduction in MACEs after controlling for known baseline variables. Our results suggested that only the lipid goal of 2.6 mmol/L was associated with a reduction in MACEs during the one-year follow-up. Patients attaining the lipid goals of 1.8 mmol/L, 2.0 mmol/L, or ≥ 50% reduction were not having fewer MACEs, and lowering the patient\'s LDL-C from 1.8--2.6 mmol/L further to \< 1.8 mmol/L did not seem to be associated with any significant clinical benefits. On the basis of our exploration on the clinical benefits and costs of lipid goal attainments in Hong Kong Chinese patients, our study questioned if the lipid goal of 2.6 mmol/L could be a better fit for Chinese patients, with significant clinical benefits and lower cardiovascular-related management costs, and raised the question of the most cost-effective lipid goal, which would need to be addressed by a prospective clinical trial. Despite the sensitivity analysis, our study has a limitation associated with real-world data (RWD). It may provide a large sample size and can be more representative of the general population, but we were unable to adjust for the confounders that were not captured in real-world clinical practice. The following could be a more cautious interpretation of our results: the reason for aiming for a more stringent lipid goal (for example, \< 1.8 mmol/L) was due to the fact that patients had multiple risk factors such as obesity, smoking, and comorbidities. This possibility was beyond our scope, and our findings were limited to the nature of the type of RWD generated from EHRs.

Given its retrospective nature, the study was limited to the following aspects. First, the main problem with the basic data was that it was retrospective and observational and had very limited power to challenge the evidence of a randomized controlled trial. The groups of patients above and below the various lipid goals during follow-up were not matched at the start when they were first identified as a CVD patient and probably differed in terms of true and original baseline lipids. Therefore, it is important to be very cautious when comparing these groups. Second, several risk factors, such as body mass index and smoking status, which might be relevant to lipid goal attainments and MACEs, were not available for the current analysis. Therefore, patients who attained the respective lipid goal could differ from those who did not attain the goal. Although we adopted the estimation of multivalued treatment effects, adjusted for the confounders at baseline, and performed sensitivity analysis, it should be still viewed as a potential violation to our results because we lacked an evaluation of the patients\' full risk profile at baseline. Third, we observed the higher cardiovascular-related costs associated with lower lipid goals but failed to identify the reason leading to the difference.

Conclusion
==========

In this first examination of the clinical outcomes and economic burden of lipid goal attainments in post-PCI Chinese patients with ACS, we found that none of the LDL-C goals of \< 2.6 mmol/L, \< 2.0 mmol/L, \< 1.8 mmol/L, and ≥ 50% reduction could lead to the reduction of the total costs of care within one-year follow-up. Furthermore, we found that any further lipid decrease could bring a remarkable economic burden on cardiovascular-related management. However, we failed to identify the clinical benefits associated with lipid goals of \< 1.8 mmol/L, 2.0 mmol/L, and ≥ 50% reduction despite of the higher cardiovascular-related costs related to these groups of patients.
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